Product

Digitalization has come to our world and healthcare system is one of its prime domains. The past decade has seen tremendous growth of electronic health care systems introduction in both state and private hospitals around the world along with various devices and applications to help collect and store health data.

This process, however, has been centered around healthcare administration, that made it difficult to use the emerging data in research purposes.

We are here to make the data work for common good.

/

Product

who we serve

Our clients

Pharmaceutical, biotech and medical device companies

For decades clinical trials data has been the gold standard for decision making in healthcare. However, this practice is currently changing towards increased use of the real world data.

This shift is helping us to better understand the unmet medical needs, patient journey, define marketing strategy, support clinical decisions and more.

Healthcare providers

The 21st Century has seen the boom in development and introduction of electronic medical records. These systems have been developed focusing on administration of patient care on healthcare facility level and, later, on state healthcare system level.

It turned out to be that the data collection and storage process was and still is not easily compatible with clinical research and practice. It is the DNA of most companies working with healthcare data to make this data available for wider research.

CROs

Modern clinical trials have been introduced back in the 20th century and gradually have become the Gold standard for evidence generation in healthcare.

So, what can we do more in this field? The answer is both simple and complicated – harness the power of digitalization of healthcare system and provide even better (ie more effective) gold standard.

Drug discovery & beyond

While RWE is becoming increasingly valuable in clinical practice and regulatory decision-making we see adoption of RWE usage across the entire drug development pipeline, including new applications of the existing molecules and expanding labels to minor or underserved patient populations.

Overall, the recent advances in data generation, standardization and analysis are bringing us closer to the world where new treatments will be produced “ex situ”, without involvement of humans and living organisms and at the speed of though or even faster.

Healthtech

Data is the building material for most digital instruments in healthcare. Indeed, the ability access world class data in healthcare can help inventions break through the new horizons.

Simulations based on real world data are helping us not only to replicate existing conditions and effect of various treatments, but also creating a much richer environments for research ultimately leading to a more sophisticated product.

T R A V E R S E
services and solutions advantages

Identification of the best available sources for the study, utilizing SPIFD framework

regulatory compliant data sets

Real world data

Development of preliminary gaps assessment for areas with additional procedures and quality control needs

Proprietary data model to convert source data

Data source verification

Clinical data to address clinical questions

Full legal compliance (GDPR, HIPAA)

Study protocol design consulting

regulatory grade RWE

Producing high-validity RWE

Quality management system (QMS) in RWE setting

Submission to institutional review board / independent ethics committee approval

Involvement of KOLs

Final / clinical study report development

Have a study in mind?

We are here to help you to lead the cutting edge studies and leverage RWD to answer your research questions

get in touch

Schedule a capabilities call with a member of our team today and get your personal solution

TRAVERSE

Türkiye
İçerenköy Mah. Kayışdağı Cad. Acıbadem Üniversitesi Tip Fakültesi C Blok, No: 32-36c Ataşehir/İstanbul, Türkiye

© 2025

The Netherlands
Fred. Roeskestraat 115, 1076 EE, Amsterdam, Netherlands